From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Nuedexta is a prescription drug used to treat pseudobulbar affect, a neurological condition involving unexpected and exaggerated crying or laughing, which may not represent the person's emotions.[1] Nuedexta consists of dextromethorphan hydrobromide, a drug often used to suppress coughs, and quinidine sulfate.[1] The pseudobulbar affect should not be confused with general emotional instability.[2]

Uses[edit | edit source]

Nuedexta is an FDA approved drug, in the United States it is only licensed for use for the pseudobulbar affect, which typically occurs in certain neurological diseases including multiple sclerosis and Parkinson's disease.[1]

Theory[edit | edit source]

Evidence[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

ME/CFS[edit | edit source]

Nuedexta is not a proposed treatment for ME/CFS and pseudobulbar effect is not typically found in patients with ME/CFS.

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 "Nuedexta: Uses, Dosage & Side Effects". Retrieved August 28, 2020.
  2. "Pseudobulbar affect Disease Reference Guide". Retrieved August 28, 2020.